178 related articles for article (PubMed ID: 24391993)
1. MspI and Ile462Val polymorphisms in CYP1A1 and overall cancer risk: a meta-analysis.
Wu B; Liu K; Huang H; Yuan J; Yuan W; Wang S; Chen T; Zhao H; Yin C
PLoS One; 2013; 8(12):e85166. PubMed ID: 24391993
[TBL] [Abstract][Full Text] [Related]
2. The cytochrome P4501A1 gene polymorphisms and endometriosis: a meta-analysis.
Fan W; Huang Z; Xiao Z; Li S; Ma Q
J Assist Reprod Genet; 2016 Oct; 33(10):1373-1383. PubMed ID: 27525656
[TBL] [Abstract][Full Text] [Related]
3. CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review.
Zhan P; Wang Q; Qian Q; Wei SZ; Yu LK
J Exp Clin Cancer Res; 2011 Oct; 30(1):99. PubMed ID: 22014025
[TBL] [Abstract][Full Text] [Related]
4. The effect of CYP1A1 polymorphisms on the risk of lung cancer: a global meta-analysis based on 71 case-control studies.
Chen Z; Li Z; Niu X; Ye X; Yu Y; Lu S; Chen Z
Mutagenesis; 2011 May; 26(3):437-46. PubMed ID: 21402622
[TBL] [Abstract][Full Text] [Related]
5. CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: evidence from a meta-analysis.
Ding G; Xu W; Liu H; Zhang M; Huang Q; Liao Z
Mol Biol Rep; 2013 May; 40(5):3483-91. PubMed ID: 23475304
[TBL] [Abstract][Full Text] [Related]
6. Does cytochrome P450 1A1 MspI polymorphism increase acute lymphoblastic leukemia risk? Evidence from 2013 cases and 2903 controls.
Zhuo W; Zhang L; Qiu Z; Zhu B; Chen Z
Gene; 2012 Nov; 510(1):14-21. PubMed ID: 22964275
[TBL] [Abstract][Full Text] [Related]
7. Association between cytochrome P450 1A1 MspI polymorphism and endometrial cancer risk: a meta-analysis.
Han L; Liu Y; Cao W; Yuan X; Li C
Tumour Biol; 2013 Oct; 34(5):2545-50. PubMed ID: 23918309
[TBL] [Abstract][Full Text] [Related]
8. The effect of CYP1A1 and CYP1A2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis.
Xue H; Lu Y; Xue Z; Lin B; Chen J; Tang F; Huang G
Tumour Biol; 2014 May; 35(5):4741-56. PubMed ID: 24443269
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 1A1 gene polymorphisms and cervical cancer risk: A systematic review and meta-analysis.
Ding B; Sun W; Han S; Cai Y; Ren M; Shen Y
Medicine (Baltimore); 2018 Mar; 97(13):e0210. PubMed ID: 29595663
[TBL] [Abstract][Full Text] [Related]
10. Combined effects of CYP1A1 MspI and GSTM1 genetic polymorphisms on risk of lung cancer: an updated meta-analysis.
Li W; Song LQ; Tan J
Tumour Biol; 2014 Sep; 35(9):9281-90. PubMed ID: 24938875
[TBL] [Abstract][Full Text] [Related]
11. Quantitative synthesis of the association between the cytochrome P450 1A1 Ile462Val polymorphism and prostate cancer risk.
Han G; Ma Y; Liu P; Wei X; Zhang X; Zhu F
Tumour Biol; 2013 Jun; 34(3):1511-6. PubMed ID: 23381648
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of the associations between CYP1A1 polymorphisms and gastric cancer risk.
Guo R; Guo X
Tumour Biol; 2012 Aug; 33(4):1125-32. PubMed ID: 22359202
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of association studies of CYP1A1 genetic polymorphisms with digestive tract cancer susceptibility in Chinese.
Liu C; Jiang Z; Deng QX; Zhao YN
Asian Pac J Cancer Prev; 2014; 15(11):4689-95. PubMed ID: 24969905
[TBL] [Abstract][Full Text] [Related]
14. Association between cytochrome P450 1A1 (CYP1A1) gene polymorphisms and the risk of renal cell carcinoma: a meta-analysis.
Meng FD; Ma P; Sui CG; Tian X; Jiang YH
Sci Rep; 2015 Jan; 5():8108. PubMed ID: 25630554
[TBL] [Abstract][Full Text] [Related]
15. CYP1A1 MspI polymorphisms and lung cancer risk: an updated meta-analysis involving 20,209 subjects.
Ji YN; Wang Q; Lin XQ; Suo LJ
Cytokine; 2012 Aug; 59(2):324-34. PubMed ID: 22579698
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 1A1 (CYP1A1) gene polymorphisms and ovarian cancer risk: a meta-analysis.
Sergentanis TN; Economopoulos KP; Choussein S; Vlahos NF
Mol Biol Rep; 2012 Nov; 39(11):9921-30. PubMed ID: 22733497
[TBL] [Abstract][Full Text] [Related]
17. CYP1A1 MspI polymorphism and acute myeloid leukemia risk: meta-analyses based on 5018 subjects.
Zhuo W; Zhang L; Wang Y; Zhu B; Chen Z
J Exp Clin Cancer Res; 2012 Jul; 31(1):62. PubMed ID: 22846179
[TBL] [Abstract][Full Text] [Related]
18. CYP1A1 Ile462Val polymorphism contributes to lung cancer susceptibility among lung squamous carcinoma and smokers: a meta-analysis.
Ji YN; Wang Q; Suo LJ
PLoS One; 2012; 7(8):e43397. PubMed ID: 22952673
[TBL] [Abstract][Full Text] [Related]
19. CYP1A1 Ile462Val is a risk factor for ovarian cancer development.
Huang M; Chen Q; Xiao J; Zhao X; Liu C
Cytokine; 2012 Apr; 58(1):73-8. PubMed ID: 22277800
[TBL] [Abstract][Full Text] [Related]
20. The interaction between smoking and CYP1A1 MspI polymorphism on lung cancer: a meta-analysis in the Chinese population.
Zhang LP; Wang CP; Li LH; Tang YF; Li WC
Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 26918783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
